APA (7th ed.) Citation

M, R., Y, W., AL, K., SA, S., LA, G., KM, W., . . . SM, G. (2025). Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders. American journal of hematology, 100(12), 2442. https://doi.org/10.1002/ajh.70093

Chicago Style (17th ed.) Citation

M, Rafati, et al. "Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders." American Journal of Hematology 100, no. 12 (2025): 2442. https://doi.org/10.1002/ajh.70093.

MLA (9th ed.) Citation

M, Rafati, et al. "Germline Pathogenic Variants in MUTYH Are Associated With Inferior Survival After Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies or Disorders." American Journal of Hematology, vol. 100, no. 12, 2025, p. 2442, https://doi.org/10.1002/ajh.70093.